Go to content
OctoPlus N.V.

OctoPlus N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 14 mei 2008 - 21:42
Statutaire naam OctoPlus N.V.
Titel OctoPlus to hold Extraordinary General Meeting of Shareholders on 30 May
Bericht OctoPlus N.V. ("OctoPlus" or the "Company") (Euronext: OCTO), the drug delivery and development company, announces today that it will hold an Extraordinary General Meeting of Shareholders (the "Meeting") on 30 May 2008 at the Company's headquarters in Leiden, in order to extend the period for preparation of its annual accounts for the year 2007 with a maximum of 6 months, until 30 November 2008. On 28 March 2008, OctoPlus announced that it had obtained a bridge financing from existing shareholders to enable the Company to secure one or more of the longer term financing options currently under negotiation. These negotiations have not been completed yet. The Company will organise an Extraordinary General Meeting of Shareholders to obtain an extension of the period for preparation of the annual accounts for the year 2007. This extension will allow the Company to prepare and provide its 2007 Annual Report to its shareholders no later than 30 November 2008, and also include the outcome of the ongoing negotiations in the 2007 Annual Report.

Datum laatste update: 28 december 2025